The gait rehabilitation system market is forecasted to reach a valuation of approximately US$ 473.69 million by 2032, expanding from its 2024 valuation of USD 356.28 million.
The market growth is driven by factors like the increasing prevalence of neurological disorders, sports injuries, orthopedic diseases, advancements in technology, and rising awareness and acceptance of gait rehabilitation systems.
North America is projected to hold the largest market share by 2035, driven by high incidences of neurological disorders and sports injuries. The Asia Pacific region is expected to hold the second-largest share, with Europe also showing significant growth, mainly due to increasing joint disorders and an aging population.
Key challenges include the availability of alternative therapies, high costs of advanced systems, limited awareness in developing regions, regulatory hurdles, and the need for specialized training and skilled personnel for operating these systems.